Preliminary results of phase II trial with combination of gemcitabine and oxaliplatin in elderly patients with advanced NSCLC.

被引：0
|
作者：
Buosi, R [1 ]
Poletti, S [1 ]
Cantele, V [1 ]
Piazza, S [1 ]
Torazzo, R [1 ]
Negru, E [1 ]
Vandone, A [1 ]
Alabiso, O [1 ]
机构：
[1] Osped Maggiore La Carita, Novara, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7348
引用
收藏
页码：703S / 703S
页数：1
相关论文
共 50 条
  • [21] Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomised phase II study
    Price, T. J.
    Townsend, A. R.
    Khattak, A.
    ANNALS OF ONCOLOGY, 2010, 21 (10) : 2121 - 2121
  • [22] Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study
    Rosati, G.
    Cordio, S.
    Bordonaro, R.
    Caputo, G.
    Novello, G.
    Reggiardo, G.
    Manzione, L.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 781 - 786
  • [23] Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients (pts) with advanced NSCLC: Preliminary results of a phase II trial.
    Hanna, NH
    Estes, D
    Cress, A
    Sidor, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 642S - 642S
  • [24] Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma. Preliminary results.
    Chauvenet, L
    Des Guetz, G
    Aparicio, T
    Boiron, C
    Ecochard, L
    Chirat, E
    Mayeur, D
    Vanica, R
    Bouleuc, C
    Paraiso, D
    Pujade-Lauraine, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 359S - 359S
  • [25] Crizotinib in Patients with ROS1 NSCLC. Preliminary Results of the AcSe Trial
    Moro-Sibilot, Denis
    Faivre, Laura
    Zalcman, Gerard
    Perol, Maurice
    Mazieres, Julien
    Barlesi, Fabrice
    Otto, Josiane
    Monnet, Isabelle
    Cortot, Alexis
    Wislez, Marie
    Lena, Herve
    Souquet, Pierre Jean
    Lantuejoul, Sylvie
    Rouquette, Isabelle
    Mcleer-Florin, Anne
    Ferretti, Gilbert
    Hoog-Labouret, Natalie
    Nowak, Freferique
    Jimenez, Marta
    Vassal, Gilles
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S374 - S374
  • [26] Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer:: Results of a GERCOR and GISCAD phase III trial
    Louvet, C
    Labianca, R
    Hammel, P
    Lledo, G
    Zampino, MG
    André, T
    Zaniboni, A
    Ducreux, M
    Aitini, E
    Taïeb, J
    Faroux, R
    Lepere, C
    de Gramont, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3509 - 3516
  • [27] Phase II study of gemcitabine (G) and cisplatin (P) in advanced NSCLC. Focus on quality of life (QoL)
    Jassem, J
    Krzakowski, M
    Roszkowski, K
    Basinska, B
    Mozejko-Pastewka, B
    Lis, J
    Miracki, K
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S250 - S251
  • [28] Gemcitabine monotherapy in elderly advanced NSCLC patients
    Altavilla, G
    Adamo, V
    Buemi, B
    Marabello, G
    Bene, A
    Lupo, G
    Chiarenza, M
    Bellocco, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S258 - S258
  • [29] Gemcitabine-Oxaliplatin combination (GEM-OHP) in metastatic non-small cell lung cancer (NSCLC): Preliminary results of a phase II study
    Lippe, Paolo
    Mazzanti, Paola
    Recchia, Francesco
    Massacesi, Cristian
    Imperatori, Luca
    Cappelletti, Claudia
    Bonsignori, Maurizio
    Mattioli, Rodolfo
    ANNALS OF ONCOLOGY, 2004, 15 : 176 - 176
  • [30] Gemcitabine in combination with doxorubicin in advanced breast cancer:: Final results of a phase II pharmacokinetic trial
    Pérez-Manga, G
    Lluch, A
    Alba, E
    Moreno-Nogueira, JA
    Palomero, M
    García-Conde, J
    Khayat, D
    Rivelles, N
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (13) : 2545 - 2552
12345